Vanderbilt University Medical Center: Novel Drugs Have Potential for Treating Tuberculosis
April 25, 2023
April 25, 2023
NASHVILLE, Tennessee, April 25 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Tuberculosis, a bacterial lung infection, is one of the leading causes of death worldwide and is becoming increasingly resistant to antibacterial treatments.
Neil Osheroff, PhD, and colleagues assessed a new class of antibacterial drugs called SPTs (spiropyrimidinetriones), which target the same enzyme, gyrase, as fluoroquinolones, the most prescribed class of bro . . .
Tuberculosis, a bacterial lung infection, is one of the leading causes of death worldwide and is becoming increasingly resistant to antibacterial treatments.
Neil Osheroff, PhD, and colleagues assessed a new class of antibacterial drugs called SPTs (spiropyrimidinetriones), which target the same enzyme, gyrase, as fluoroquinolones, the most prescribed class of bro . . .